Will President-elect Trump endorse Medicare and Medicaid coverage for anti-obesity medications by March 2025? | Binary | | | 27 days ago | |
FDA actions against counterfeit Mounjaro or Zepbound by December 31, 2024 | Categorical | | | 6 months ago | |
WHO warning on counterfeit weight-loss drugs by December 31, 2024? | Binary | | | 6 months ago | |
FDA statement on counterfeit Mounjaro or Zepbound by September 30, 2024? | Binary | | | 6 months ago | |
Lawsuit resolution against counterfeit sellers by end of 2024? | Binary | | | 6 months ago | |
Will the FDA take action against fake Mounjaro and Zepbound products by end of 2024? | Binary | | | 6 months ago | |
How will Eli Lilly's stock price react to the crackdown on fake medications by September 30, 2024? | Categorical | | | 6 months ago | |
How many settlements will be reached in lawsuits over fake Mounjaro and Zepbound by end of 2024? | Categorical | | | 6 months ago | |
Will Eli Lilly issue a new warning about fake GLP-1 medications by September 30, 2024? | Binary | | | 6 months ago | |
Will Eli Lilly win the lawsuit against six entities by end of 2024? | Binary | | | 6 months ago | |
Construction Start of Eli Lilly's New Facility Before 2026 | Binary | | | 7 months ago | |
Eli Lilly Market Share by End of 2026 | Categorical | | | 7 months ago | |
Competitors introduce similar products by October 2024? | Binary | | | 7 months ago | |
Eli Lilly to expand Tirzepatide production due to high demand in China by H2 2024? | Binary | | | 7 months ago | |
New approvals for Tirzepatide's additional indications in China by 2024 | Categorical | | | 7 months ago | |
Number of Tirzepatide competitors entering China by 2024 | Categorical | | | 7 months ago | |
Tirzepatide overtakes rival in sales in its first quarter in China? | Binary | | | 7 months ago | |
Eli Lilly begins Tirzepatide sales in China by end of 2024? | Binary | | | 7 months ago | |
Market share of Tirzepatide in China by end of 2024 | Categorical | | | 7 months ago | |
Will Zepbound receive expanded insurance coverage for sleep apnea by June 30, 2025? | Binary | | | 2 days ago | |
Most prescribed diabetes drug in Europe by end of 2025? | Categorical | | | 9 days ago | |
Will Eli Lilly's 2024 EPS exceed revised guidance? | Binary | | | 2 months ago | |
Insurance covers GLP-1 agonists for substance use disorder by October 2025? | Binary | | | 2 months ago | |
CDC reports decline in overdose deaths for 2024 by March 2025? | Binary | | | 2 months ago | |
Will Eli Lilly's Q3 2024 EPS meet or exceed $4.00? | Binary | | | 5 months ago | |
Eli Lilly's next major legal move against counterfeit drugs by October 31, 2024 | Categorical | | | 6 months ago | |
How many additional entities will Eli Lilly sue over fake medications by end of 2024? | Categorical | | | 6 months ago | |
FDA Approval for Mounjaro by end of 2025 | Binary | | | 7 months ago | |
Revenue from New Drugs in First Year After Release | Categorical | | | 7 months ago | |
Completion of New Facility on Schedule by 2028 | Categorical | | | 7 months ago | |
Nestlé's 'Vital Pursuit' hits $50 million in sales by April 2024? | Binary | | | 7 months ago | |
Market share of 'Vital Pursuit' by October 2024 | Categorical | | | 7 months ago | |
Consumer satisfaction for 'Vital Pursuit' by October 2024 | Categorical | | | 7 months ago | |
Stock price increase due to 'Vital Pursuit' by October 2024 | Categorical | | | 7 months ago | |
Nestlé expands 'Vital Pursuit' product line by October 2024? | Binary | | | 7 months ago | |
Will the FDA issue new guidelines for compounding pharmacies on obesity drugs by December 31, 2025? | Binary | | | 2 days ago | |
Will Eli Lilly's stock price increase by 10% or more by March 31, 2025? | Binary | | | 2 days ago | |
Will Medicare and Medicaid beneficiaries receive anti-obesity medication coverage by June 2025? | Binary | | | 27 days ago | |
Which company will see the highest sales increase from Medicare and Medicaid anti-obesity drug coverage by end of 2025? | Categorical | | | 27 days ago | |
Will Medicaid cover weight-loss drugs for 4 million adults by June 2025? | Binary | | | 27 days ago | |
Will UK authorities complete Mounjaro investigation by December 31, 2024? | Binary | | | 1 month ago | |
Will Novo Nordisk recall Mounjaro globally by June 30, 2025? | Binary | | | 1 month ago | |
Will Eli Lilly's stock recover to pre-Q3 earnings level by Dec 31, 2024? | Binary | | | 2 months ago | |
Eli Lilly's 2024 revenue vs revised guidance | Categorical | | | 2 months ago | |
Eli Lilly's Q4 2024 revenue vs analyst expectations | Categorical | | | 2 months ago | |
Will Mounjaro sales reach $3.5 billion in Q4 2024? | Binary | | | 2 months ago | |
Will Eli Lilly's Mounjaro revenue surpass $4 billion in Q4 2024? | Binary | | | 2 months ago | |
Will Eli Lilly revise its full-year EPS guidance upwards by March 2025? | Binary | | | 2 months ago | |
Will Eli Lilly's stock price recover to pre-earnings levels by end of 2024? | Binary | | | 2 months ago | |
What will be Eli Lilly's full-year 2024 revenue? | Categorical | | | 2 months ago | |
What will be the percentage change in Eli Lilly's stock price post Q4 2024 earnings? | Categorical | | | 2 months ago | |
Will Eli Lilly shares recover to pre-Q3 2024 levels by end of 2024? | Binary | | | 2 months ago | |
Will Mounjaro sales reach $3.62 billion in Q4 2024? | Binary | | | 2 months ago | |
What will be Eli Lilly's adjusted EPS for Q4 2024? | Categorical | | | 2 months ago | |
What will be Eli Lilly's revenue growth rate for 2024? | Categorical | | | 2 months ago | |
What will be Mounjaro's market share in HK weight-loss drugs by end of 2025? | Categorical | | | 2 months ago | |
Will Mounjaro sell over 100,000 units in Hong Kong Q1 2025? | Binary | | | 2 months ago | |
Will Eli Lilly's stock ($LLY) reach a new all-time high by end of 2024? | Binary | | | 2 months ago | |
First organization to recommend GLP-1 agonists for opioid risk reduction by end of 2025? | Categorical | | | 2 months ago | |
Will the FDA approve GLP-1 agonists for addiction treatment by end of 2025? | Binary | | | 2 months ago | |
Which company will announce a GLP-1 agonist study for addiction by end of 2025? | Categorical | | | 2 months ago | |
Will Eli Lilly's stock price increase by 10% or more by end of 2024 due to Zepbound's success? | Binary | | | 4 months ago | |
Will Eli Lilly's Q3 2024 revenue meet or exceed the raised guidance? | Binary | | | 5 months ago | |
Will Zepbound sales exceed $1.5 billion in Q3 2024? | Binary | | | 5 months ago | |
What will Eli Lilly's total revenue for 2024 be? | Categorical | | | 5 months ago | |
What will Mounjaro's sales be in Q3 2024? | Categorical | | | 5 months ago | |
What will Eli Lilly's stock price be at the end of 2024? | Categorical | | | 5 months ago | |
Will Novo Nordisk announce a new weight loss drug by end of 2024? | Binary | | | 6 months ago | |
Outcome of Eli Lilly's lawsuits against counterfeit sellers by end of 2024 | Categorical | | | 6 months ago | |
FDA Approval for Zepbound by end of 2025 | Binary | | | 7 months ago | |
Market share changes among obesity drug manufacturers by December 31, 2025 | Categorical | | | 2 days ago | |
Number of new Zepbound prescriptions for sleep apnea by June 30, 2025 | Categorical | | | 2 days ago | |
Impact of Zepbound on sleep apnea treatment costs by December 31, 2025 | Categorical | | | 2 days ago | |
Outcome of vision loss study related to Ozempic by end of 2025? | Categorical | | | 9 days ago | |
Novo Nordisk issues safety update or recall for Ozempic over vision loss by end of 2025? | Binary | | | 9 days ago | |
Mounjaro surpasses Ozempic in European diabetes treatment market share by end of 2025? | Binary | | | 9 days ago | |
Increase in Ozempic prescriptions in Europe post-EMA label update by June 2025? | Binary | | | 9 days ago | |
Primary reason for Ozempic prescription increase in Europe post-EMA update by June 2025? | Categorical | | | 9 days ago | |
What will be the revised cost estimate for Medicare coverage of anti-obesity medications by end of 2025? | Categorical | | | 27 days ago | |
How many Medicare beneficiaries will receive anti-obesity medications by end of 2025? | Categorical | | | 27 days ago | |
Will Medicare and Medicaid coverage for anti-obesity medications be finalized by end of 2025? | Binary | | | 27 days ago | |
Approval of Medicare Coverage for Weight-Loss Drugs by End of 2025 | Binary | | | 27 days ago | |
Finalization of Medicare Weight-Loss Drug Proposal by End of 2024 | Binary | | | 27 days ago | |
Price Reduction for Wegovy in US Market by 2025 | Binary | | | 27 days ago | |
Top Beneficiary of Medicare Weight-Loss Drug Coverage by 2025 | Categorical | | | 27 days ago | |
Cost Impact of Medicare Weight-Loss Drug Coverage by 2026 | Categorical | | | 27 days ago | |
Weight-Loss Drug with Highest Medicare Claims by End of 2025 | Categorical | | | 27 days ago | |
How many Americans will access weight-loss drugs via Medicare and Medicaid by end of 2025? | Categorical | | | 27 days ago | |
How will Novo Nordisk and Eli Lilly stocks react within 3 months of Medicare and Medicaid coverage implementation? | Categorical | | | 27 days ago | |
What will be the outcome of the Medicare and Medicaid weight-loss drug coverage proposal by end of 2024? | Categorical | | | 27 days ago | |
Will Medicare and Medicaid cover weight-loss drugs by end of 2024? | Binary | | | 27 days ago | |
Will Wegovy and Mounjaro be covered by Medicare by March 2025? | Binary | | | 27 days ago | |
Will the UK suspend Mounjaro use by March 31, 2025? | Binary | | | 1 month ago | |
What will be the outcome of the UK investigation into Mounjaro by March 31, 2025? | Categorical | | | 1 month ago | |
How many additional countries will suspend Mounjaro by June 30, 2025? | Categorical | | | 1 month ago | |
What will be the change in Novo Nordisk's stock price by end of Q1 2025 due to Mounjaro issues? | Categorical | | | 1 month ago | |
Will Eli Lilly meet its revised 2024 EPS guidance? | Binary | | | 2 months ago | |
Eli Lilly's stock performance vs competitors by end of Q4 2024 | Categorical | | | 2 months ago | |
Which will be Eli Lilly's top-performing product by revenue in Q4 2024? | Categorical | | | 2 months ago | |
Which will be Eli Lilly's top-selling drug in Q4 2024? | Categorical | | | 2 months ago | |